Medicaid

Christine Cooper, Founder and CEO, aequum, Leads Discussion on Healthcare Price Transparency Panel at SIIA Spring Forum 2024

Retrieved on: 
Tuesday, March 19, 2024

aequum LLC , which serves more than 425 self-insured health plans and their participants, today announces that Christine Cooper, founder and CEO, aequum and co-chair of the Self-Insurance Institute of America, Inc. (SIIA) Price Transparency Committee , will be participating in a 75-minute discussion on Healthcare Price Transparency at the SIIA Spring Forum.

Key Points: 
  • aequum LLC , which serves more than 425 self-insured health plans and their participants, today announces that Christine Cooper, founder and CEO, aequum and co-chair of the Self-Insurance Institute of America, Inc. (SIIA) Price Transparency Committee , will be participating in a 75-minute discussion on Healthcare Price Transparency at the SIIA Spring Forum.
  • We must ensure they are better prepared to navigate the Independent Dispute Resolution Process and make informed healthcare decisions."
  • Cooper’s panel will examine crucial topics discussed at SIIA’s Healthcare Transparency Forum in February, distilling the most pertinent and timely content shared with attendees at that event.
  • By facilitating discussions like these and providing actionable insights, we strive to create a more transparent and equitable healthcare system for all."

Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant

Retrieved on: 
Monday, March 18, 2024

“CDA Foundation is very proud to have been selected to distribute these grants,” commented Homie Razavi, the Managing Director of CDA Foundation.

Key Points: 
  • “CDA Foundation is very proud to have been selected to distribute these grants,” commented Homie Razavi, the Managing Director of CDA Foundation.
  • “Loss of diagnosed but untreated patients is a major barrier for countries trying to achieve the viral hepatitis elimination targets.
  • The submission window for the second round of proposals opened in February 2024 for programs with a duration of no more than 18 months.
  • For more information, please visit https://cdafound.org/relink or contact CDA Foundation at [email protected] .

GlobalData Report Highlights Staggering Economic Costs for Alabama of $7.2 Billion Due to Obesity

Retrieved on: 
Thursday, March 14, 2024

GlobalData’s report, ‘ Obesity’s Impact on Alabama's Economy and Labor Force ,’ analyzes the economic and workforce implications of obesity in the State of Alabama, as well as the impact on state tax revenue collections and costs.

Key Points: 
  • GlobalData’s report, ‘ Obesity’s Impact on Alabama's Economy and Labor Force ,’ analyzes the economic and workforce implications of obesity in the State of Alabama, as well as the impact on state tax revenue collections and costs.
  • Obesity is a serious, progressive disease and is associated with a range of other diseases, including type 2 diabetes, cardiovascular diseases, and musculoskeletal disorders.
  • In Alabama, approximately one-third of adults are classified as having obesity (38.3%), and another third have overweight (33.7%) in 2022.
  • Employers in Alabama paid an extra $822 million in higher medical expenditures for health complications attributed to obesity and overweight.

LIBERTY Dental Plan Launches Innovations in Oral Health with Generative Artificial Intelligence (GenAI) Capabilities in Care Management and Enhancements to Its Benefits and Rewards for Utilization, Services, and Healthy Outcomes (B.R.U.S.H.®) Program

Retrieved on: 
Thursday, March 14, 2024

By leveraging GenAI, LIBERTY ensures that its case managers can efficiently navigate the complexities of case management, ultimately leading to best-in-class patient care.

Key Points: 
  • By leveraging GenAI, LIBERTY ensures that its case managers can efficiently navigate the complexities of case management, ultimately leading to best-in-class patient care.
  • program, a Value-Based Care healthcare delivery model specifically designed for the child Medicaid population that rewards providers based on healthy patient outcomes.
  • program actively involves the dental care team in ensuring patients' oral health, while also encouraging beneficiaries to establish and maintain a dental health home program and follow proper oral health routines—ultimately improving long-term oral health and wellness.
  • “By proactively detecting oral health problems before they occur, LIBERTY strives to improve the overall oral health and well-being of our members.”

Innovaccer Announces Acquisition of Pharmacy Quality Solutions to Accelerate Value-Based Care in Pharmacy Settings

Retrieved on: 
Tuesday, March 12, 2024

Today, Innovaccer , a leading healthcare company, has announced the completion of its acquisition of Pharmacy Quality Solutions (PQS), a leader in Pharmacy-Payer performance technology.

Key Points: 
  • Today, Innovaccer , a leading healthcare company, has announced the completion of its acquisition of Pharmacy Quality Solutions (PQS), a leader in Pharmacy-Payer performance technology.
  • This strategic move reinforces Innovaccer’s commitment to accelerating value-based care across the healthcare ecosystem and have the largest distribution of providers and pharmacy network combined.
  • PQS covers 95% of all community pharmacies and 10 of the Top 10 Pharmacy chains by store count including national chains and independent pharmacy groups.
  • “The possibilities that this acquisition brings to Innovaccer and our valued stakeholders pave a new area of growth.

HCAP Partners Leads Formation of PAX Health

Retrieved on: 
Tuesday, March 12, 2024

HCAP Partners , a California-based private equity firm and nationally recognized impact investor, alongside seasoned healthcare executives Anthony DeSena and Roy Leitstein, today announced the acquisitions of Behavioral Medicine Associates (BMA), Workers Compensation Psychological Network (WCPN), and Reservoir Health , merging under PAX Health (PAX).

Key Points: 
  • HCAP Partners , a California-based private equity firm and nationally recognized impact investor, alongside seasoned healthcare executives Anthony DeSena and Roy Leitstein, today announced the acquisitions of Behavioral Medicine Associates (BMA), Workers Compensation Psychological Network (WCPN), and Reservoir Health , merging under PAX Health (PAX).
  • The combination of the three businesses under the PAX Health umbrella creates one of the largest behavioral health businesses in the Northeastern U.S. and allows PAX to extend the full continuum of care to patients.
  • Additionally, HCAP will help accelerate job quality improvements for PAX Health professionals through its proprietary Gainful Jobs Approach™ , an impact framework that focuses on career advancement, economic opportunity, diversity, and health and wellness.
  • “We’re thrilled to partner with HCAP as we expand our footprint and access to mental healthcare,” said Anthony DeSena, CEO of PAX Health.

Anthem Blue Cross and Blue Shield Recognized for Significant Improvements in Key Quality of Care Measures

Retrieved on: 
Tuesday, March 12, 2024

According to the latest New York State Department of Health’s Consumer’s Guide to Medicaid and Child Health Plus Managed Care Plans, Anthem Blue Cross and Blue Shield saw a significant jump in ratings in multiple, high priority categories.

Key Points: 
  • According to the latest New York State Department of Health’s Consumer’s Guide to Medicaid and Child Health Plus Managed Care Plans, Anthem Blue Cross and Blue Shield saw a significant jump in ratings in multiple, high priority categories.
  • Overall, Anthem was one of the highest scoring Medicaid plans in New York, achieving increases for both Cardiovascular and Maternal Care, while Adult Care increased from 2 to 5 Stars.
  • More stars translate to better healthcare for the 555,000 Medicaid enrollees served by Anthem.
  • We work tirelessly with our members, their providers and the communities where they live to ensure that each and every member receives the highest quality of care,” said Mark Levy, President and CEO Anthem Blue Cross and Blue Shield.

Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2023

Retrieved on: 
Tuesday, March 12, 2024

Revenues from Customer Care / Outsourced Services in the fourth quarter were $1.4 million, compared to $3.1 million in the prior year period.

Key Points: 
  • Revenues from Customer Care / Outsourced Services in the fourth quarter were $1.4 million, compared to $3.1 million in the prior year period.
  • Adjusted EBITDA for the fourth quarter was $4.5 million compared to $2.3 million in the prior year period.
  • Revenues for the full year ended December 31, 2023 were $113.7 million, compared to revenues of $109.2 million in the prior year.
  • The Company will hold a conference call to discuss its fourth quarter and full year 2023 results today at 5:00 p.m. Eastern.

Priority Health Executive Named Top Woman Leader in Health Care by National Outlet

Retrieved on: 
Monday, March 11, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240311383262/en/
    Joyce Chan Russell, Senior Vice President of Government Markets at Priority Health.
  • (Photo: Business Wire)
    This national recognition honors women executives who are helping develop policy, leading change and making advancements across all sectors of the health care industry.
  • In her role at Priority Health, Chan Russell oversees the individual, Medicare Advantage and Medicaid businesses, as well as population health and health equity.
  • “Since joining Priority Health in 2021, Joyce has consistently demonstrated exceptional leadership through her ability to balance the pace of change with our desire to innovate,” said Praveen Thadani, president of Priority Health.

bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy

Retrieved on: 
Monday, March 11, 2024

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA™ (lovotibeglogene autotemcel, also known as lovo-cel) with the state of Michigan.

Key Points: 
  • bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio”) today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA™ (lovotibeglogene autotemcel, also known as lovo-cel) with the state of Michigan.
  • LYFGENIA is a one-time gene therapy approved for the treatment of patients 12 years of age and older with sickle cell disease and a history of vaso-occlusive events (VOEs).
  • Approximately 50 percent of individuals living with sickle cell disease in the U.S. are insured by Medicaid.
  • “Our commercial approach is built on the principle that people with sickle cell disease insured through Medicaid deserve the same timely access to gene therapy as patients with other forms of insurance,” said Tom Klima, chief commercial & operating officer, bluebird bio.